Drug
KDT-3594 clinical trials
Also written KDT-3594.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
- KDT-3594
- 4
Studies by the year they started
4 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses KDT-3594 is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's DiseaseCompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT06722729Written as KDT-3594
- A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseCompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT04867551Written as KDT-3594
- A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.CompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT03845387Written as KDT-3594
- Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's DiseaseCompletedPhase 1Kissei Pharmaceutical Co., Ltd.NCT03068481Written as KDT-3594